Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul E R Ellery

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Seminars in Thrombosis and Hemostasis|November 8, 2014
Tissue factor pathway inhibitor: then and nowPaul E R Ellery, Murray J Adams
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 28, 2007
Further insight into the heparin-releasable and glycosylphosphatidylinositol-lipid--anchored forms of tissue factor pathway inhibitorPaul E R Ellery, Kathy Hardy, Robert Oostryck, et al.
Blood|March 13, 2014
Biology of tissue factor pathway inhibitorJeremy P Wood, Paul E R Ellery, Susan A Maroney, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2013
Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitorJeremy P Wood, Paul E R Ellery, Susan A Maroney, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2013
Translation of human tissue factor pathway inhibitor-β mRNA is controlled by alternative splicing within the 5' untranslated regionPaul E R Ellery, Susan A Maroney, Nicholas D Martinez, et al.
Blood Advances|June 6, 2017
Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable StateJeremy P Wood, Lisa M Baumann Kreuziger, Paul E R Ellery, et al.
Research and Practice in Thrombosis and Haemostasis|January 23, 2018
Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein SPaul E R Ellery, Ida Hilden, Ken Sejling, et al.
Blood|May 9, 2015
A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic developmentPaul E R Ellery, Susan A Maroney, Brian C Cooley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 15, 2019
Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophiliaPaul E R Ellery, Ida Hilden, Peter Thyregod, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Thrombosis and Hemostasis|November 8, 2014
Tissue factor pathway inhibitor: then and nowPaul E R Ellery, Murray J Adams
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 28, 2007
Further insight into the heparin-releasable and glycosylphosphatidylinositol-lipid--anchored forms of tissue factor pathway inhibitorPaul E R Ellery, Kathy Hardy, Robert Oostryck, et al.
Blood|March 13, 2014
Biology of tissue factor pathway inhibitorJeremy P Wood, Paul E R Ellery, Susan A Maroney, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2013
Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitorJeremy P Wood, Paul E R Ellery, Susan A Maroney, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2013
Translation of human tissue factor pathway inhibitor-β mRNA is controlled by alternative splicing within the 5' untranslated regionPaul E R Ellery, Susan A Maroney, Nicholas D Martinez, et al.
Blood Advances|June 6, 2017
Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable StateJeremy P Wood, Lisa M Baumann Kreuziger, Paul E R Ellery, et al.
Research and Practice in Thrombosis and Haemostasis|January 23, 2018
Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein SPaul E R Ellery, Ida Hilden, Ken Sejling, et al.
Blood|May 9, 2015
A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic developmentPaul E R Ellery, Susan A Maroney, Brian C Cooley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 15, 2019
Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophiliaPaul E R Ellery, Ida Hilden, Peter Thyregod, et al.
Pageof 1